BIEL stock performance?

Pink Sheets: BioElectronics Corporation (BIEL) news stock charts

BioElectronics Corporation (BIEL/BIEL.PK) Penny Investment Summary:

BioElectronics Corporation, a development stage company, develops and markets drug-free anti-inflammatory patches. The company's products include ActiPatch Therapy, a dermal drug-free, painless, and pulsed energy patch with an embedded battery operated microchip that delivers pulsed electromagnetic frequency therapies to accelerate healing of soft tissue injuries. Its technology provides pulsed electromagnetic energy therapy that is used to reduce swelling, relieve pain, and enhance the healing of post-surgical incisions, chronic wounds, and orthopedic conditions. The company has market clearance/approval for its products in the United States, Canada, and Europe. BioElectronics Corporation s...
www.bielcorp.com
Founded in 2000

BIOELECTRONICS CORP (BIEL:OTC)

LAST $0.03 USD
CHANGE TODAY -0.0011 -3.28%
VOLUME 6.1M
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of BIOELECTRONICS CORP (BIEL)

OPEN
$0.03
PREVIOUS CLOSE
$0.03
DAY HIGH
$0.03
DAY LOW
$0.03
52 WEEK HIGH
09/11/09 - $0.12
52 WEEK LOW
05/7/09 - $0.0011
MARKET CAP
--
AVERAGE VOLUME 10 D
8.2M
EPS TTM
--
SHARES OUTSTANDING
0.0
BIEL Does Not Pay Dividends
P/E TTM
--
K = Thousands  M = Millions  B = Billions

Key developments for BIOELECTRONICS CORP (BIEL)

BioElectronics Corporation Upgrades ActiPatch Therapy(R) Product Line

BioElectronics Corp. announced a major upgrade to its ActiPatch Therapy(R) product line. The upgrade consists of a new methodology for attaching the Company's patented technology to the human body. Beginning effectively with the next product manufacturing run, all ActiPatch Therapy(R) products will utilize a new type of flexible and highly durable elastic strap with Velcro ends that will enable users to place this award winning technology directly over the site of their pain or inflammation.

BioElectronics Corporation Enters into Distribution Agreement with SAY-GIN Ozel Egtim Yayincilik Ticaret Hizmetleri

BioElectronics Corp. announced it has reached an agreement with SAY-GIN Ozel Egtim Yayincilik Ticaret Hizmetleri (SAY-GIN) for distribution of its ActiPatch and Allay products in Turkey. SAY-GIN has already committed to orders totaling more than $1 million in 2010. SAY-GIN is launching a direct response television campaign in Turkey to support sales of both the ActiPatch and Allay product lines.

YesDTC Holdings, Inc. Acquires Japanese Distribution Rights for ActiPatch (TM) Therapy from BioElectronics Corp

YesDTC Holdings, Inc. has completed negotiations with BioElectronics Corp. to begin distribution of ActiPatch(TM) Therapy disposable drug-free anti-inflammatory device throughout Japan. Under the terms of the arrangement, YesDTC will hold full television, direct-to-consumer and retail distribution rights to consumers within Japan. YesDTC plans to initially launch distribution through direct response television advertising and is currently formulating plans for retail launch. ActiPatch is currently categorized within Japan as a Class I medical device.

BioElectronics Corporation financial resources

otc, otcbb, pinksheet, BIEL, ob BioElectronics Corporation

BIEL Competitors

Company Last Change
Diapulse Corp America/Del $0.20 USD +0.03
Ivivi Technologies Inc $0.02 USD 0.00
Kinetic Concepts Inc $49.15 USD -0.61
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation BIEL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

BIEL

BIEL transactions

Type
Date
Target
No transactions in the last 6 months.

Pink Sheets: More Recent Financial News About BioElectronics Corporation

BioElectronics Launches Latin America Campaign - Initial Results Show Strong Sales for Allay Menstrual Pain Therapy

Quote: For the past several years we have been working to strengthenour corporate infrastructure, complete clinical studies, position ourbrands, and to establish international distributors and partners,”commented Andrew Whelan, CEO of BioElectronics. “With most of the hardwork relative to these initiatives behind us, we are now focusing ourattention on revenue generation and we are pleased to announce todaythis new initiative will be a major contributor. We are also pleased tosee strong evi...
Read article

BioTech Stock Alert for BioElectronics Corp. Issued by StockPreacher

Quote: The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.http://www.stockpreacher.com/n/BIELhttp://twitter.com/StockPreacherBioElectronics Corp. (BIEL) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-in...
Read article

BioTech Stock Alert for BioElectronics Corp. Issued by StockPreacher

Quote: The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.http://www.stockpreacher.com/n/BIELhttp://twitter.com/StockPreacherBioElectronics Corp. (BIEL) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-in...
Read article

Part Two of a Two Part Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is Now at SmallCapVoice.com

Quote: announced today that part 2 of a 2 part newaudio interview with BioElectronics Corp. (Pink Sheets: - ), the makerof inexpensive, disposable drug-free anti-inflammatory devices is nowavailable. The interview can be heard at SmallCapVoice.com is a recognized corporate investor relations firm,with clients nationwide, known for its ability to help emerging growthcompanies build a following among retail and institutional investors.SmallCapVoice.com utilizes its stock newsletter to feature its dailyst...
Read article

Part One of a Two Part Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is Now at SmallCapVoice.com

Quote: announced today that part 1 of a 2 part newaudio interview with BioElectronics Corp. (Pink Sheets:- ), the makerof inexpensive, disposable drug-free anti-inflammatory devices is nowavailable. The interview can be heard at SmallCapVoice.com is a recognized corporate investor relations firm,with clients nationwide, known for its ability to help emerging growthcompanies build a following among retail and institutional investors.SmallCapVoice.com utilizes its stock newsletter to feature its dailysto...
Read article

Part Two of a Two Part Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is Now at SmallCapVoice.com

Quote: announced today that part 2 of a 2 part newaudio interview with BioElectronics Corp. (Pink Sheets: - ), the makerof inexpensive, disposable drug-free anti-inflammatory devices is nowavailable. The interview can be heard at SmallCapVoice.com is a recognized corporate investor relations firm,with clients nationwide, known for its ability to help emerging growthcompanies build a following among retail and institutional investors.SmallCapVoice.com utilizes its stock newsletter to feature its dailyst...
Read article

Part One of a Two Part Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is Now at SmallCapVoice.com

Quote: announced today that part 1 of a 2 part newaudio interview with BioElectronics Corp. (Pink Sheets:- ), the makerof inexpensive, disposable drug-free anti-inflammatory devices is nowavailable. The interview can be heard at SmallCapVoice.com is a recognized corporate investor relations firm,with clients nationwide, known for its ability to help emerging growthcompanies build a following among retail and institutional investors.SmallCapVoice.com utilizes its stock newsletter to feature its dailysto...
Read article

BioElectronics Announces Product Upgrades

Quote: The upgrade consists ofa new methodology for attaching the Company’s patented technology to thehuman body.Beginning effectively with the next product manufacturing run, allActiPatch Therapy® products will utilize a new type of flexible andhighly durable elastic strap with Velcro ends that will enable users toplace this award winning technology directly over the site of their painor inflammation.“This is a very exciting development for BioElectronics. While ourinitial products wer...
Read article

BioElectronics Announces Completed Audits

Quote: BIELNews), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the completion of an independent audit which covered a three-year period ending on December 31, 2008 and a period from April 2000 through December 2008.The audit’s findings showed that BioElectronics have increased sales every year over the past three years and estimated the pain relief market potential to be $10 billion. The audit was conducted by the CPA firm Berenfeld Spritzer Shechter ...
Read article

BioElectronics Announces Turkey Infomercial Program Expansion

Quote: Press ReleaseSource: BioElectronics Corp.On Monday February 8, 2010, 9:00 am ESTFREDERICK, Md.--(BUSINESS WIRE)--BioElectronics Corp. (PINKSHEETS:- “We are very excited about expanding into Turkey and are looking forward to working with SAY-GIN,” said BioElectronics Vice President Sales and Marketing, Arnon Horev. “Turkey has the 15 largest gross domestic product, putting it in the same neighborhood as Canada (14th) and “With SAY-GIN’s commitment to orders in 2010,...
Read article

BioElectronics Announces Turkey Infomercial Program Expansion

Quote: Press ReleaseSource: BioElectronics Corp.On Monday February 8, 2010, 9:00 am ESTFREDERICK, Md.--(BUSINESS WIRE)--BioElectronics Corp. (PINKSHEETS:- “We are very excited about expanding into Turkey and are looking forward to working with SAY-GIN,” said BioElectronics Vice President Sales and Marketing, Arnon Horev. “Turkey has the 15 largest gross domestic product, putting it in the same neighborhood as Canada (14th) and “With SAY-GIN’s commitment to orders in 2010,...
Read article

BioElectronics Announces Product Upgrades

Quote: The upgrade consists ofa new methodology for attaching the Company’s patented technology to thehuman body.Beginning effectively with the next product manufacturing run, allActiPatch Therapy® products will utilize a new type of flexible andhighly durable elastic strap with Velcro ends that will enable users toplace this award winning technology directly over the site of their painor inflammation.“This is a very exciting development for BioElectronics. While ourinitial products wer...
Read article

YesDTC Acquires Japanese Distribution Rights for ActiPatch(TM) Therapy from BioElectronics Corp.

Quote: ActiPatch is currently categorized within Japan as a Class I medical device."We are looking forward to working closely with everyone at BioElectronics to launch distribution into what will likely become a very significantly sized market for the ActiPatch Therapy brand," commented Joe Noel, CEO of YesDTC Holdings, Inc."We have already placed a substantial order with BioElectronics and expect product shipments from the Company over the short term. In order to address the Japanese market we are ali...
Read article

BioElectronics Announces Completed Audits

Quote: BIELNews), the maker of inexpensive,disposable drug-free anti-inflammatory devices, today announced thecompletion of an independent audit which covered a three-year periodending on December 31, 2008 and a period from April 2000 throughDecember 2008.The audit’s findings showed that BioElectronics have increased salesevery year over the past three years and estimated the pain reliefmarket potential to be $10 billion. The audit was conducted by the CPAfirm Berenfeld Spritzer Shechter & Sheer...
Read article

BioElectronics Signs Deal to Enter Japanese Market

Quote: (YESD.OB) to enter theJapanese market and receipt of the single largest product order andrevenue commitment in company history.Shipments of initial products are expected to begin in the first quarterof 2010 with additional shipments expected throughout the year.“We are very excited about our entry into the Japanese market as webelieve consumers will be highly receptive to our drug-free painrelieving and healing technology,” said Arnon Horev, BioElectronics VicePresident of Marketing....
Read article

YesDTC Acquires Japanese Distribution Rights for ActiPatch(TM) Therapy from BioElectronics Corp.

Quote: YESDNewsBIELNews)  to begin distribution of the award-winning ActiPatch™ Therapy disposable drug-free anti-inflammatory device throughout Japan.Under the terms of the arrangement, YesDTC will hold full television, direct-to-consumer and retail distribution rights to consumers within the world's second largest economy. YesDTC plans to initially launch distribution through direct response television advertising and is currently formulating plans for retail launch. ActiPatch is curre...
Read article

BioElectronics Announces Worldwide DRTV Strategy

Quote: BIELNews), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands.The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lu...
Read article

BioElectronics Ends 2009 with International Product and Partner Gains

Quote: As a result, BioElectronics isexpecting significant gains in international markets throughout 2010.Mr. Andrew Whelan, CEO of BioElectronics provides the following updateto investors and other stakeholders:“Earlier in 2009, we had stated that our corporate priorities were thecompletion of clinical studies, United States Food and DrugAdministration (FDA) filings and the building of our brands. I ampleased to say this management team has helped BioElectronics makeexcellent strides in these ar...
Read article

InvestorSoup Initiates Independent Market Coverage for BioElectronics Corp.

Quote: The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision. http://www.investorsoup.com/lp/BIEL www.twitter.com/investorsoup BioElectronics Corp. (BIEL) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, ...
Read article

BioElectronics to Become Fully Reporting Company

Quote: BIELNews), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the Company would soon become a fully reporting company.The related filings will offer investors in BioElectronics full transparency into the Company's financials and financial operations."As we indicated several months ago, BioElectronics has engaged a professional auditing firm to review our financials in order to provide our investors, distributors and other stakeholders an accurate and unbias...
Read article

Would you like to leave a comment about BioElectronics Corporation BIEL/BIEL.PK

Besides BioElectronics Corporation's Penny Stock there is more great penny stock and market information at Realpennies